{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T03:24:49Z","timestamp":1764905089072,"version":"3.40.5"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"am","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.leukres.2025.107676","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T16:14:53Z","timestamp":1740759293000},"page":"107676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical and therapeutic significance of genetic profiling in adult T-cell leukemia\/lymphoma"],"prefix":"10.1016","volume":"151","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1158-5131","authenticated-orcid":false,"given":"Yasunori","family":"Kogure","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8263-9902","authenticated-orcid":false,"given":"Keisuke","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.leukres.2025.107676_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrc2111","article-title":"Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation","volume":"7","author":"Matsuoka","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.leukres.2025.107676_bib2","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S1470-2045(14)70202-5","article-title":"Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma","volume":"15","author":"Ishitsuka","year":"2014","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.leukres.2025.107676_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1200\/JCO.18.00501","article-title":"Revised adult T-cell leukemia-lymphoma international consensus meeting report","volume":"37","author":"Cook","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.leukres.2025.107676_bib4","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/cas.13303","article-title":"Genetic alterations in adult T-cell leukemia\/lymphoma","volume":"108","author":"Kogure","year":"2017","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.leukres.2025.107676_bib5","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1111\/cas.15097","article-title":"Epidemiology of adult T-cell leukemia-lymphoma in Japan: an updated analysis, 2012-2013","volume":"112","author":"Ito","year":"2021","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.leukres.2025.107676_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12977-020-0511-0","article-title":"HTLV-1 bZIP factor: the key viral gene for pathogenesis","volume":"17","author":"Matsuoka","year":"2020","journal-title":"Retrovirology"},{"issue":"1","key":"10.1016\/j.leukres.2025.107676_bib7","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/s41467-021-25101-9","article-title":"Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma","volume":"12","author":"Yamagishi","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.leukres.2025.107676_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1158\/2643-3230.BCD-21-0044","article-title":"Single-cell analysis of the multicellular ecosystem in viral carcinogenesis by HTLV-1","volume":"2","author":"Koya","year":"2021","journal-title":"Blood Cancer Discov."},{"issue":"24","key":"10.1016\/j.leukres.2025.107676_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI150472","article-title":"HTLV-1 infection promotes excessive T cell activation and transformation into adult T cell leukemia\/lymphoma","volume":"131","author":"Tan","year":"2021","journal-title":"J. Clin. Invest"},{"issue":"11","key":"10.1016\/j.leukres.2025.107676_bib10","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat. Genet"},{"issue":"7","key":"10.1016\/j.leukres.2025.107676_bib11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1182\/blood.2021013568","article-title":"Whole-genome landscape of adult T-cell leukemia\/lymphoma","volume":"139","author":"Kogure","year":"2022","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.leukres.2025.107676_bib12","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2018-01-824607","article-title":"North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies","volume":"132","author":"Shah","year":"2018","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.leukres.2025.107676_bib13","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41375-020-0900-3","article-title":"Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia\/lymphoma and defines an unfavorable indolent subtype","volume":"35","author":"Mar\u00e7ais","year":"2021","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.leukres.2025.107676_bib14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/cas.14806","article-title":"Genetic profile of adult T-cell leukemia\/lymphoma in Okinawa: association with prognosis, ethnicity, and HTLV-1 strains","volume":"112","author":"Sakihama","year":"2021","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.leukres.2025.107676_bib15","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2025.107676_bib16","unstructured":"WHO classification tumours editorial board, Haematolymphoid tumours [Internet], 2024. \u3008https:\/\/tumourclassification.iarc.who.int\/chapters\/63\u3009. (Accessed 2024-09-07."},{"issue":"8","key":"10.1016\/j.leukres.2025.107676_bib17","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated Anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2025.107676_bib18","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.13338","article-title":"Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study","volume":"169","author":"Ishida","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"34","key":"10.1016\/j.leukres.2025.107676_bib19","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1200\/JCO.2016.67.7732","article-title":"Multicenter phase ii study of lenalidomide in relapsed or recurrent adult T-cell leukemia\/lymphoma: ATLL-002","volume":"34","author":"Ishida","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.leukres.2025.107676_bib20","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1111\/cas.15431","article-title":"Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia\/lymphoma: phase IIb results","volume":"113","author":"Utsunomiya","year":"2022","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.leukres.2025.107676_bib21","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.2022016862","article-title":"An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia\/lymphoma","volume":"141","author":"Izutsu","year":"2023","journal-title":"Blood"},{"issue":"10168","key":"10.1016\/j.leukres.2025.107676_bib22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","article-title":"Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial","volume":"393","author":"Horwitz","year":"2019","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.leukres.2025.107676_bib23","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1002\/cncr.25147","article-title":"A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma: a multicenter clinicopathologic experience and new prognostic score","volume":"116","author":"Phillips","year":"2010","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.leukres.2025.107676_bib24","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.2011.38.2101","article-title":"Prognostic index for acute- and lymphoma-type adult T-cell leukemia\/lymphoma","volume":"30","author":"Katsuya","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.leukres.2025.107676_bib25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bjh.12962","article-title":"Japan Clinical Oncology Group (JCOG) prognostic index and characterization of long-term survivors of aggressive adult T-cell leukaemia-lymphoma (JCOG0902A)","volume":"166","author":"Fukushima","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"7","key":"10.1016\/j.leukres.2025.107676_bib26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.3324\/haematol.2017.164996","article-title":"Development of a modified prognostic index for patients with aggressive adult T-cell leukemia-lymphoma aged 70 years or younger: possible risk-adapted management strategies including allogeneic transplantation","volume":"102","author":"Fuji","year":"2017","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.leukres.2025.107676_bib27","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1200\/JCO.1997.15.5.1778","article-title":"Deletions of p15 and\/or p16 genes as a poor-prognosis factor in adult T-cell leukemia","volume":"15","author":"Yamada","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.leukres.2025.107676_bib28","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1182\/blood.V79.2.477.477","article-title":"Mutations of the p53 gene in adult T-cell leukemia","volume":"79","author":"Sakashita","year":"1992","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.leukres.2025.107676_bib29","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1182\/blood.V91.10.3935","article-title":"Mutation of CD95 (Fas\/Apo-1) gene in adult T-cell leukemia cells","volume":"91","author":"Tamiya","year":"1998","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2025.107676_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036269","article-title":"The impact of next-generation sequencing on cancer genomics: from discovery to clinic","volume":"9","author":"Mardis","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med"},{"issue":"12","key":"10.1016\/j.leukres.2025.107676_bib31","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1038\/s41375-019-0473-1","article-title":"Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling","volume":"33","author":"Watatani","year":"2019","journal-title":"Leukemia"},{"issue":"13","key":"10.1016\/j.leukres.2025.107676_bib32","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1158\/0008-5472.CAN-24-0132","article-title":"Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK\/T-cell lymphoma","volume":"84","author":"Ito","year":"2024","journal-title":"Cancer Res"},{"issue":"13","key":"10.1016\/j.leukres.2025.107676_bib33","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1084\/jem.20140987","article-title":"Gain-of-function CCR4 mutations in adult T cell leukemia\/lymphoma","volume":"211","author":"Nakagawa","year":"2014","journal-title":"J. Exp. Med"},{"issue":"33","key":"10.1016\/j.leukres.2025.107676_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav1263","article-title":"CD4 T cell sphingosine 1-phosphate receptor (S1PR)1 and S1PR4 and endothelial S1PR2 regulate afferent lymphatic migration","volume":"4","author":"Xiong","year":"2019","journal-title":"Sci. Immunol."},{"issue":"7607","key":"10.1016\/j.leukres.2025.107676_bib35","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.leukres.2025.107676_bib36","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/s41375-019-0380-5","article-title":"Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas","volume":"33","author":"Kataoka","year":"2019","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.leukres.2025.107676_bib37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.cell.2006.11.038","article-title":"ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology","volume":"127","author":"Lam","year":"2006","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.leukres.2025.107676_bib38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1947601911421925","article-title":"The c-Rel transcription factor in development and disease","volume":"2","author":"Gilmore","year":"2011","journal-title":"Genes Cancer"},{"issue":"32","key":"10.1016\/j.leukres.2025.107676_bib39","doi-asserted-by":"crossref","first-page":"51981","DOI":"10.18632\/oncotarget.10223","article-title":"Adult T-cell leukemia\/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy","volume":"7","author":"Zell","year":"2016","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.leukres.2025.107676_bib40","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1002\/cncr.25147","article-title":"O.A. O\u2032Connor, A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia\/lymphoma","volume":"116","author":"Phillips","year":"2010","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.leukres.2025.107676_bib41","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","article-title":"Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry","volume":"16","author":"Pastore","year":"2015","journal-title":"Lancet Oncol."},{"issue":"17","key":"10.1016\/j.leukres.2025.107676_bib42","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1200\/JCO.2018.78.9867","article-title":"MIPSS70+\u2009Version 2.0: mutation and karyotype-enhanced international prognostic scoring system for primary myelofibrosis","volume":"36","author":"Tefferi","year":"2018","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.leukres.2025.107676_bib43","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200008","article-title":"Molecular international prognostic scoring system for myelodysplastic syndromes","volume":"1","author":"Bernard","year":"2022","journal-title":"NEJM Evid."},{"issue":"2","key":"10.1016\/j.leukres.2025.107676_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/blood-2017-01-761874","article-title":"Prognostic relevance of integrated genetic profiling in adult T-cell leukemia\/lymphoma","volume":"131","author":"Kataoka","year":"2018","journal-title":"Blood"},{"issue":"34","key":"10.1016\/j.leukres.2025.107676_bib45","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","article-title":"VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan clinical oncology group study JCOG9801","volume":"25","author":"Tsukasaki","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.leukres.2025.107676_bib46","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.3324\/haematol.2022.281510","article-title":"Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia\/lymphoma","volume":"108","author":"Kameda","year":"2023","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.leukres.2025.107676_bib47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nri3403","article-title":"T cell receptor signalling networks: branched, diversified and bounded","volume":"13","author":"Brownlie","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"22","key":"10.1016\/j.leukres.2025.107676_bib48","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-04-0983","article-title":"The CC chemokine receptor 4 as a novel specific molecular target for immunotherapy in adult T-Cell leukemia\/lymphoma","volume":"10","author":"Ishida","year":"2004","journal-title":"Clin. Cancer Res"},{"issue":"5","key":"10.1016\/j.leukres.2025.107676_bib49","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-09-2697","article-title":"Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia\/lymphoma","volume":"16","author":"Ishii","year":"2010","journal-title":"Clin. Cancer Res"},{"issue":"28","key":"10.1016\/j.leukres.2025.107676_bib50","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","article-title":"Pretransplantation anti-CCR4 antibody mogamulizumab against adult T-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality","volume":"34","author":"Fuji","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.leukres.2025.107676_bib51","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood-2018-02-835991","article-title":"CCR4 mutations associated with superior outcome of adult T-cell leukemia\/lymphoma under mogamulizumab treatment","volume":"132","author":"Sakamoto","year":"2018","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.leukres.2025.107676_bib52","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1182\/blood.2021014468","article-title":"Resistance to mogamulizumab is associated with loss of CCR4 in cutaneous T-cell lymphoma","volume":"139","author":"Beygi","year":"2022","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.leukres.2025.107676_bib53","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2015-07-567958","article-title":"The novel mechanism of lenalidomide activity","volume":"126","author":"Fink","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.leukres.2025.107676_bib54","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2016-02-698092","article-title":"Targeted sequencing of refractory myeloma reveals a high incidence of mutations in CRBN and Ras pathway genes","volume":"128","author":"Kort\u00fcm","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.leukres.2025.107676_bib55","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1038\/s41467-022-31430-0","article-title":"The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma","volume":"13","author":"Vo","year":"2022","journal-title":"Nat. Commun."},{"issue":"8002","key":"10.1016\/j.leukres.2025.107676_bib56","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-024-07103-x","article-title":"Mechanisms of action and resistance in histone methylation-targeted therapy","volume":"627","author":"Yamagishi","year":"2024","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.leukres.2025.107676_bib57","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1111\/cas.15427","article-title":"Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies","volume":"113","author":"Fukuhara","year":"2022","journal-title":"Cancer Sci."},{"issue":"11","key":"10.1016\/j.leukres.2025.107676_bib58","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1158\/2159-8290.CD-22-0417","article-title":"C-CAT: The national datacenter for cancer genomic medicine in Japan","volume":"12","author":"Kohno","year":"2022","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.leukres.2025.107676_bib59","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1158\/2159-8290.CD-23-0902","article-title":"Pan-cancer comparative and integrative analyses of driver alterations using Japanese and international genomic databases","volume":"14","author":"Horie","year":"2024","journal-title":"Cancer Discov."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625000360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212625000360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:17:56Z","timestamp":1747239476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212625000360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":59,"alternative-id":["S0145212625000360"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107676","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and therapeutic significance of genetic profiling in adult T-cell leukemia\/lymphoma","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2025.107676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107676"}}